Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 5 studies | 19% ± 6% | |
hepatocyte | 5 studies | 42% ± 20% | |
pancreatic A cell | 4 studies | 45% ± 5% | |
type B pancreatic cell | 4 studies | 42% ± 15% | |
epithelial cell | 4 studies | 33% ± 18% | |
fibroblast | 4 studies | 21% ± 5% | |
enteroendocrine cell | 3 studies | 28% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 1063.65 | 180 / 180 | 100% | 47.23 | 430 / 430 |
liver | 100% | 5936.45 | 226 / 226 | 100% | 48.97 | 405 / 406 |
thymus | 100% | 1448.14 | 653 / 653 | 100% | 49.77 | 603 / 605 |
brain | 100% | 776.00 | 2631 / 2642 | 100% | 26.99 | 705 / 705 |
prostate | 100% | 1400.93 | 245 / 245 | 99% | 31.17 | 498 / 502 |
stomach | 100% | 587.61 | 359 / 359 | 99% | 22.77 | 283 / 286 |
adrenal gland | 100% | 1253.52 | 258 / 258 | 99% | 20.14 | 227 / 230 |
uterus | 100% | 1254.25 | 170 / 170 | 99% | 20.54 | 453 / 459 |
intestine | 100% | 573.21 | 963 / 966 | 99% | 23.69 | 521 / 527 |
pancreas | 100% | 776.38 | 328 / 328 | 98% | 26.59 | 175 / 178 |
esophagus | 98% | 629.69 | 1420 / 1445 | 99% | 24.18 | 181 / 183 |
skin | 99% | 1217.88 | 1799 / 1809 | 98% | 25.21 | 461 / 472 |
breast | 100% | 3676.59 | 459 / 459 | 96% | 19.44 | 1076 / 1118 |
bladder | 100% | 845.05 | 21 / 21 | 96% | 22.42 | 485 / 504 |
lung | 100% | 1065.41 | 576 / 578 | 97% | 17.28 | 1115 / 1155 |
kidney | 100% | 1088.40 | 89 / 89 | 96% | 19.08 | 865 / 901 |
adipose | 100% | 2775.60 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 49.06 | 80 / 80 |
spleen | 100% | 525.55 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 13.69 | 1 / 1 |
blood vessel | 99% | 673.10 | 1321 / 1335 | 0% | 0 | 0 / 0 |
muscle | 99% | 636.12 | 793 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 17.87 | 44 / 45 |
heart | 95% | 631.25 | 822 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 90% | 9.91 | 26 / 29 |
peripheral blood | 59% | 252.39 | 545 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006656 | Biological process | phosphatidylcholine biosynthetic process |
GO_0006686 | Biological process | sphingomyelin biosynthetic process |
GO_0001835 | Biological process | blastocyst hatching |
GO_0032259 | Biological process | methylation |
GO_0120162 | Biological process | positive regulation of cold-induced thermogenesis |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0031966 | Cellular component | mitochondrial membrane |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005829 | Cellular component | cytosol |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0080101 | Molecular function | phosphatidyl-N-dimethylethanolamine N-methyltransferase activity |
GO_0004608 | Molecular function | phosphatidylethanolamine N-methyltransferase activity |
GO_0000773 | Molecular function | phosphatidyl-N-methylethanolamine N-methyltransferase activity |
Gene name | PEMT |
Protein name | Phosphatidylethanolamine N-methyltransferase (PEAMT) (PEMT) (EC 2.1.1.17) (EC 2.1.1.71) (PEMT2) (Phospholipid methyltransferase) (PLMT) Phosphatidylethanolamine N-methyltransferase (PEAMT) (PEMT) (EC 2.1.1.17) (EC 2.1.1.71) (Phospholipid methyltransferase) (PLMT) Phosphatidylethanolamine N-methyltransferase |
Synonyms | PNMT PEMPT |
Description | FUNCTION: Catalyzes the three sequential steps of the methylation pathway for the biosynthesis of phosphatidylcholine, a critical and essential component for membrane structure. Uses S-adenosylmethionine (S-adenosyl-L-methionine, SAM or AdoMet) as the methyl group donor for the methylation of phosphatidylethanolamine (1,2-diacyl-sn-glycero-3-phosphoethanolamine, PE) to phosphatidylmonomethylethanolamine (1,2-diacyl-sn-glycero-3-phospho-N-methylethanolamine, PMME), PMME to phosphatidyldimethylethanolamine (1,2-diacyl-sn-glycero-3-phospho-N,N-dimethylethanolamine, PDME), and PDME to phosphatidylcholine (1,2-diacyl-sn-glycero-3-phosphocholine, PC), producing S-adenosyl-L-homocysteine in each step. . FUNCTION: Catalyzes the three sequential steps of the methylation pathway for the biosynthesis of phosphatidylcholine, a critical and essential component for membrane structure . Uses S-adenosylmethionine (S-adenosyl-L-methionine, SAM or AdoMet) as the methyl group donor for the methylation of phosphatidylethanolamine (1,2-diacyl-sn-glycero-3-phosphoethanolamine, PE) to phosphatidylmonomethylethanolamine (1,2-diacyl-sn-glycero-3-phospho-N-methylethanolamine, PMME), PMME to phosphatidyldimethylethanolamine (1,2-diacyl-sn-glycero-3-phospho-N,N-dimethylethanolamine, PDME), and PDME to phosphatidylcholine (1,2-diacyl-sn-glycero-3-phosphocholine, PC), producing S-adenosyl-L-homocysteine in each step . Responsible for approximately 30% of hepatic PC with the CDP-choline pathway accounting for the other 70% (Probable). .; FUNCTION: [Isoform 1]: Catalyzes the three sequential steps of the methylation of 1,2-diacyl-sn-glycero-3-phospho-N-methylethanolamine (PMME) to 1,2-diacyl-sn-glycero-3-phospho-N,N-dimethylethanolamine (PDME) more efficiently than isoform 2 . Induces increase in PC species with longer polyunsaturated chains than isoform 2 . .; FUNCTION: [Isoform 2]: Produces a higher increase in the level of PC species containing long chains with three double bonds than isoform 1. . FUNCTION: Catalyzes the three sequential steps of the methylation pathway for the biosynthesis of phosphatidylcholine, a critical and essential component for membrane structure. Uses S-adenosylmethionine (S-adenosyl-L-methionine, SAM or AdoMet) as the methyl group donor for the methylation of phosphatidylethanolamine (1,2-diacyl-sn-glycero-3-phosphoethanolamine, PE) to phosphatidylmonomethylethanolamine (1,2-diacyl-sn-glycero-3-phospho-N-methylethanolamine, PMME), PMME to phosphatidyldimethylethanolamine (1,2-diacyl-sn-glycero-3-phospho-N,N-dimethylethanolamine, PDME), and PDME to phosphatidylcholine (1,2-diacyl-sn-glycero-3-phosphocholine, PC), producing S-adenosyl-L-homocysteine in each step. . |
Accessions | ENST00000255389.10 [Q9UBM1-2] ENST00000580147.5 ENST00000395782.5 [Q9UBM1-1] D3YTC7 ENST00000435340.6 Q9UBM1 J3QLU8 ENST00000395783.5 [Q9UBM1-1] J3KTR2 ENST00000395781.6 [Q9UBM1-3] Q71UY0 ENST00000461404.1 |